Indian contract research organisation in Ahmedabad, Gujarat, founded in 1998 by Shivprakash Rathnam and among the first private Indian companies to offer bioequivalence studies and clinical trial monitoring. Runs bioequivalence, bioavailability and pharmacokinetic and pharmacodynamic studies from phase one to phase four with bioanalysis, statistical analysis and data management. The European Medicines Agency found irregularities in bioequivalence studies carried out at the site and in September 2022 its human medicines committee confirmed the suspension of marketing authorisations for a number of generic medicines tested there.
コメントはありません。
評価とコメントを残す